Integrated Animal Health teams with university; Survey calls for pet generics; Gour enters into agreement to develop doggie downers;

> Integrated Animal Health said it will enter into a 10-year agreement with Northwest Missouri State University to partner with the Dean L. Hubbard Center for Innovation and Entrepreneurship to conduct testing and laboratory trials to improve herd health for production animals. Release

> Pet pharma company Putney released a poll that said 100% of the veterinary participants believed offering generic prescription alternatives for pet owners is "the right thing to do." Announcement

> Veterinary biomed company Gour Medical entered into an agreement with Actelion Pharmaceuticals to develop an early-stage drug that would be used to treat anxiety, hypervigilance and restlessness in dogs during stressful situations. Release

> Kindred Biosciences ($KIN) reported a year-end 2014 net loss of $27.1 million compared to a net loss of $4.2 million for the same period in 2013. Announcement

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…